Back

Results - Announcements

Sales rise 19.63% to Rs 627.63 crore

Epigral consolidated net profit rises 12.45% in the March 2025 quarter

05-May-2025, 05:23
Net profit of Epigral rose 12.45% to Rs 86.89 crore in the quarter ended March 2025 as against Rs 77.27 crore during the previous quarter ended March 2024. Sales rose 19.63% to Rs 627.63 crore in the quarter ended March 2025 as against Rs 524.63 crore during the previous quarter ended March 2024.

For the full year,net profit rose 82.62% to Rs 357.69 crore in the year ended March 2025 as against Rs 195.87 crore during the previous year ended March 2024. Sales rose 32.19% to Rs 2550.13 crore in the year ended March 2025 as against Rs 1929.19 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	627.63	524.63	20	2550.13	1929.19	32
OPM %	27.62	29.62	-	27.87	24.94	-
PBDT	165.28	143.83	15	673.65	414.31	63
PBT	131.33	113.45	16	541.09	290.75	86
NP	86.89	77.27	12	357.69	195.87	83